We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.9B
AUM Growth
-$1.68B
Cap. Flow
-$856M
Cap. Flow %
-1.56%
Top 10 Hldgs %
13.5%
Holding
2,578
New
206
Increased
762
Reduced
975
Closed
423

Top Buys

Rank Stock Value
1
DPZ icon
Domino's
DPZ
+$76.7M
2
UNH icon
UnitedHealth
UNH
+$75.4M
3
EQR icon
Equity Residential
EQR
+$65.9M
4
AEP icon
American Electric Power
AEP
+$56.3M
5
EHC icon
Encompass Health
EHC
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.16%
2 Financials 15.86%
3 Technology 13.23%
4 Energy 9.84%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEWT icon
2276
NewtekOne
NEWT
$417M
-6,500
Closed -$120K
NGNE icon
2277
Neurogene
NGNE
$696M
-30
Closed -$7K
NOVT icon
2278
Novanta
NOVT
$5.04B
-600
Closed -$30K
NRC icon
2279
NRC Health Common Stock
NRC
$474M
-8,840
Closed -$330K
NWS icon
2280
News Corp Class B
NWS
$16.4B
-136,687
Closed -$2.27M
OCGN icon
2281
Ocugen
OCGN
$410M
-78
Closed -$10K
OCUL icon
2282
Ocular Therapeutix
OCUL
$1.86B
-6,900
Closed -$31K
IMDX
2283
Insight Molecular Diagnostics
IMDX
$153M
-70
Closed -$7K
OFS icon
2284
OFS Capital
OFS
$43.8M
-11,285
Closed -$134K
OLED icon
2285
Universal Display
OLED
$3.71B
-66,811
Closed -$11.5M
ORMP icon
2286
Oramed Pharmaceuticals
ORMP
$165M
-3,499
Closed -$32K
PAM icon
2287
Pampa Energía
PAM
$4.64B
-44,500
Closed -$2.99M
PBYI icon
2288
Puma Biotechnology
PBYI
$406M
-300
Closed -$30K
PFLT icon
2289
PennantPark Floating Rate Capital
PFLT
$681M
-1,739
Closed -$24K
PFSI icon
2290
PennyMac Financial
PFSI
$4.38B
-167
Closed -$4K
PFX icon
2291
PhenixFIN
PFX
-290
Closed -$30K
PGC icon
2292
Peapack-Gladstone Financial
PGC
$822M
-8,375
Closed -$293K
PLUR icon
2293
Pluri
PLUR
$19.2M
-76
Closed -$8K
PMTS icon
2294
CPI Card Group
PMTS
$224M
-8,640
Closed -$32K
POWL icon
2295
Powell Industries
POWL
$8.46B
-7,650
Closed -$73K
PROV icon
2296
Provident Financial
PROV
$108M
-3,773
Closed -$69K
PRQR icon
2297
ProQR Therapeutics
PRQR
$243M
-2,900
Closed -$9K
PSTV icon
2298
Plus Therapeutics
PSTV
$26.4M
0
-$10K
PTCT icon
2299
PTC Therapeutics
PTCT
$6.37B
-600
Closed -$10K
BCIC
2300
BCP Investment Corp
BCIC
$86.9M
-890
Closed -$30K

Similar funds

Macquarie Group's Q1 2018 Portfolio in Review

As of Q1 2018, Macquarie Group held 2,578 positions worth $54.9B, down 3% from $56.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group's Q1 2018 filing shows 206 new, 762 increased, 975 reduced and 423 closed positions. Its largest new stake was Nutrien: 773,043 shares worth $36.5M. The largest sale was Celgene Corp, an estimated $165M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q1 2018 buy was Nutrien: 773,043 shares worth $36.5M.
  • Macquarie Group added most to Domino's in Q1 2018, an estimated $76.7M increase.
  • Macquarie Group's biggest Q1 2018 reduction was Celgene Corp, cutting an estimated $165M.
  • Macquarie Group fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $50.4M.
  • Macquarie Group's ten largest holdings make up 13% of its $54.9B portfolio in Q1 2018.
  • Macquarie Group opened 206 new positions and closed 423 in Q1 2018.
  • Macquarie Group's portfolio value fell 3% quarter-over-quarter to $54.9B.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.